Latest News for: microangiopathy

Edit

SeqOne Genomics and the French Thrombotic MicroAngiopathies National Reference Center (CNR-MAT) Pioneer the Use of Oxford Nanopore Sequencing Technology to Improve Patient Outcomes in Kidney Disease While Reducing Turnaround Times

Pharmiweb 09 Feb 2023
Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome (aHUS) ... About the French Thrombotic Microangiopathies National reference centre (CNR-MAT).
Edit

Kira Pharmaceuticals Receives FDA Clearance of IND Application for Phase 2 Evaluation of KP104 in Systemic Lupus Erythematosus Associated Thrombotic Microangiopathy (SLE-TMA)

PR Newswire 03 Oct 2022
The Phase 2 trial will evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of KP104 in participants with systemic lupus erythematosus associated thrombotic microangiopathy (SLE-TMA) in the US, China, and Australia.
Edit

North America Thrombotic Microangiopathy (TMA) Market Research Report Analysis By Competition, Sales, Revenue, Market Size ...

MENA FN 27 Sep 2022
(MENAFN - America News Hour) CRIFAX added a report on 'North America Thrombotic Microangiopathy (TMA) Market, 2023-2033 to its database of market research collaterals consisting of overall market ... .
Edit

Biomedical engineers find imaging technique could become treatment for deep vein thrombosis

Technology Org 29 Jul 2021
Biomedical engineers at Penn State set out to develop technology capable of localizing and imaging blood clots in deep veins. It turns out that their work may not only identify blood clots, it may also be able to treat them. The U.S. National Science Foundation-funded team, led by Scott Medina, published the results in Advance Healthcare Materials.
Edit

Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Following the Opening of its IND

Pharmiweb 23 Dec 2019
Part A of the trial is a dose confirmation study ... New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation associated thrombotic microangiopathy ... bullous pemphigoid (BP), atopic keratoconjunctivitis (AKC), thrombotic microangiopathy (TMA), and paroxysmal nocturnal hemoglobinuria (PNH) ... .
Edit

Omeros Reports Positive Data Across Primary and Secondary Endpoints in Pivotal Trial of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy Patients Treated with Narsoplimab

Public Technologies 04 Dec 2019
OMER) today announced positive data from its pivotal clinical trial of the company's novel investigational complement inhibitor narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a frequently lethal complication of HSCT.
Edit

Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting

Pharmiweb 02 Dec 2019
Food and Drug Administration (FDA). ... New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation associated thrombotic microangiopathy ... 2016 April; 54(2) ... bullous pemphigoid (BP), atopic keratoconjunctivitis (AKC), thrombotic microangiopathy (TMA), and paroxysmal nocturnal hemoglobinuria (PNH) ... .
Edit

Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)

Nasdaq Globe Newswire 30 Aug 2019
NEW YORK and LONDON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq ... Food and Drug Administration (FDA) has granted orphan drug designation for nomacopan for the treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) ... .
Edit

Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

Public Technologies 14 Aug 2019
Food and Drug Administration (FDA) has granted Fast Track designation for nomacopan for the treatment of hematopoietic stem cell transplant associated thrombotic microangiopathy (HSCT-TMA) in pediatric patients ... microangiopathy (TMA), and paroxysmal nocturnal hemoglobinuria (PNH).
Edit

Omeros Announces Clinical Strategy to Accelerate Pediatric Development of OMS721 for the Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)

Public Technologies 06 Dec 2018
OMER) today announced that it has submitted a pediatric investigational plan (PIP) for the use of OMS721 for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) to the European Medicines Association (EMA) ... Thrombotic microangiopathy ...
Edit

FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Public Technologies 23 Oct 2018
Food and Drug Administration (FDA) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) ... Thrombotic microangiopathy is a life-threatening complication of HSCT, with reported mortality of greater than 90 percent in some high-risk patients.
Edit

Akari Therapeutics Announces New Clinical Data in Post-Transplant Thrombotic Microangiopathies. Data Supports Akari’s Ongoing Clinical ...

Nasdaq Globe Newswire 01 Oct 2018
... company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement and or leukotriene systems are implicated, today announced new clinical data in post-transplant thrombotic microangiopathies.

Most Viewed

Philippine President Ferdinand Marcos Jr., greets residents during his visit a day after a strong quake struck Bangued, Abra province, northern Philippines on Thursday, July 28, 2022
AP / Malacanang Presidential Photographers Division
This image released by ANSAR ALLAH HOUTHI MEDIA OFFICE, shows the aftermath of a deadly stampede in Sanna, Yemen Wednesday, April 19, 2023. A crowd apparently spooked by gunfire and an electrical explosion stampeded at an event to distribute financial aid during the Muslim holy month of Ramadan in Yemen’s capital late Wednesday, according to witnesses and Houthi rebel officials.
AP / ANSAR ALLAH HOUTHI MEDIA OFFICE via AP
×